Mettler-Toledo International (NYSE:MTD) Issues FY 2026 Earnings Guidance

Key Points

• FY 2026 guidance: Mettler-Toledo issued EPS guidance of 46.30–46.95 (consensus 46.51) and revenue guidance of $4.2 billion, with Q2 EPS guided to 10.70–10.85.
• Analyst opinions shifted: Several firms adjusted targets and ratings (Morgan Stanley and Barclays cut targets; Jefferies and Wall Street Zen upgraded to buys), leaving a consensus of "Moderate Buy" with a $1,459.58 target.
• Recent performance and activity: Shares fell to $1,320.43 on the update amid above-average volume, after the company reported a quarter EPS beat ($13.36 vs. $12.76) and revenue of $1.13B; the CFO sold 800 shares recently.

Mettler-Toledo International (NYSE:MTD - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 46.300-46.950 for the period, compared to the consensus EPS estimate of 46.510. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q2 2026 guidance to 10.700-10.850 EPS.

Analyst Ratings Changes

Several research firms have recently weighed in on MTD. Morgan Stanley reduced their target price on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an "equal weight" rating for the company in a report on Tuesday, February 10th. Barclays reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an "overweight" rating for the company in a research note on Tuesday, April 14th. Jefferies Financial Group raised Mettler-Toledo International from a "hold" rating to a "buy" rating and upped their price objective for the company from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Finally, Wall Street Zen raised Mettler-Toledo International from a "hold" rating to a "buy" rating in a research note on Saturday, February 14th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $1,459.58.

Mettler-Toledo International Price Performance

Shares of MTD stock traded down $6.61 during trading hours on Thursday, reaching $1,320.43. 198,733 shares of the company's stock were exchanged, compared to its average volume of 150,680. The company has a market cap of $26.74 billion, a P/E ratio of 31.35, a price-to-earnings-growth ratio of 2.73 and a beta of 1.31. The company's 50 day moving average is $1,277.68 and its two-hundred day moving average is $1,367.88. Mettler-Toledo International has a 1 year low of $1,077.19 and a 1 year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $12.76 by $0.60. The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company's revenue for the quarter was up 8.1% on a year-over-year basis. During the same period in the prior year, the business posted $12.41 EPS. As a group, analysts predict that Mettler-Toledo International will post 46.51 EPS for the current fiscal year.

Insider Activity

In other news, CFO Shawn Vadala sold 800 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer directly owned 5,288 shares of the company's stock, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.71% of the company's stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of large investors have recently modified their holdings of the business. Geneos Wealth Management Inc. boosted its stake in shares of Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier's stock valued at $78,000 after acquiring an additional 30 shares during the last quarter. Baird Financial Group Inc. raised its stake in Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier's stock valued at $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC raised its stake in Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier's stock valued at $476,000 after purchasing an additional 125 shares during the last quarter. Cerity Partners LLC boosted its stake in shares of Mettler-Toledo International by 10.8% during the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier's stock worth $4,740,000 after purchasing an additional 392 shares during the last quarter. Finally, AXA S.A. boosted its stake in shares of Mettler-Toledo International by 2.9% during the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier's stock worth $5,433,000 after purchasing an additional 131 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.